Program

€150 million raised. What will convince these investors to back your company?
Our panelists have collectively raised €150 million and are ready to invest. Having convinced their own investors to commit capital in a difficult market, where will they place their bets—and what will they expect from entrepreneurs? This panel brings together HealthTech fund managers to debate how the demands of their backers shape investment decisions. Does a tougher fundraising environment encourage bold investments in differentiated innovation, or favor companies with clearer, faster paths to returns? How much room is there for scientific ambition when investors face pressure to deliver?
For entrepreneurs, this is a chance to understand what happens on the other side of the negotiating table: what these newly raised funds are looking for, what makes a company compelling, and where investors disagree. Expect a candid debate about who gets funded, who gets passed over, and why.